...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: US to shell out $1.2B for sup­plies of Mer­ck­'s po­ten­tial Covid-19 an­tivi­ral.

Hey, you're right Tada on that $705 per course! That's why it's important to keep an eye out for the competition here! We blow them out of the water re pricing, now we just need to see how we do in human trials!

They've got Merck though, and...here we go again on the FDA/BP political angle.

Share
New Message
Please login to post a reply